Thyroid function analysis and other biochemical parameters in patients with moderate and severe COVID-19

Dler Rostum Ali

doi:10.15218/zjms.2022.026

Authors

Dler Rostum Ali Department of Basic Science, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2022.026

Keywords:

COVID-19, TSH, T3, T4, Sodium, Potassium, Chloride

Abstract

Background and objective: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease-19 (COVID-19). The effects of COVID-19 on the thyroid axis remain uncertain. This study aimed to determine the occurrence of thyroid dysfunction, as previously demonstrated for SARS-CoV-1 infection, and to analyze electrolytes (sodium, potassium, and chloride) to determine the severity of the disease.

Methods: Blood samples were taken from patients who were admitted to Erbil hospitals from July to October 2021. Infection was detected by polymerase chain reaction (PCR). The 306 cases were labeled as moderate or severe. The samples were assessed for doing C-reactive protein (CRP), as a marker of systemic inflammation, thyroid-stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4), and (sodium, potassium, and chloride) electrolytes.

Results: Patients comprised of 157 (51.3%) males and 149 (48.7%) females. The result revealed that 274 (89.5%), 278 (90.8%), 292 (95.4%) of patients had normal TSH, T3, T4 level respectively, 22 (7.2%), 23 (7.5%), 9 (2.9%) of patients had low TSH, T3, T4 level respectively, and 10 (3.3%), 5 (1.6%), 5 (1.6%), had high TSH, T3, T4 level respectively. There was no significant difference between moderate and severe cases in alterations of TSH, T3, T4 level. There was a significant difference between moderate and severe cases in sodium, potassium, and chloride electrolyte abnormality.

Conclusion: The occurrence of thyroid dysfunction in moderate and severe cases. The severity of the COVID-19 infection is associated with abnormalities in sodium, calcium, and chloride electrolytes.

Metrics

Metrics Loading ...

References

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708–20.

Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020; 183(4):381–7. https://doi.org/10.1530/EJE-20-0335.

Duntas LH, Jonklaas J. COVID-19 and Thyroid Diseases: A Bidirectional Impact. Journal of the Endocrine Society. 2021; 5(8):1–11.

Asghar MS, Yasmin F,Dapke K, Phadke R, Shah SMI, Zafar MDB. Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience. J Med Virol. 2021; 93(10):5712–7.

COVID-19 pandemic Wikipedia [Internet]. En. wikipedia.org 2021. https://en.wikipedia.org/wiki/COVID-19 pandemic. 2021.

Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019. Intern Med. 2020; 288(3):335–44.

European Center for Disease Prevention and Control. Clinical characteristics of COVID-19. Reteived. 2021.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683–90. https://doi.org/10.1001/jamaneurol.2020.1127.

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020; 382(17):1653–59.

Garg M, Gopalakrishnan M, Yadav P, Misra S. Endocrine involvement in COVID-19: mechanisms, clinical features, and implications for care. Indian J Endocrinol Metab. 2020; 24(5):381–6.

Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update.Rev Endocr Metab Disord. 2021; 22(4):803–15.

Malik J, Malik A, Javaid M, Zahid T, Ishaq U, Shoaib M. Thyroid function analysis in COVID-19: A retrospective study from a single center. PLoS ONE. 2021; 16(3):e0249421. https://doi.org/10.1371/journal.pone.0249421.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223):497–506.

Chang L, Yan Y, Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev. 2020; 34(2):75–80.

Giovanella L, Ruggeri RM, Petranović OP, Campenni A, Treglia G, Deandreis D. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists. Eur J Nucl Med Mol Imaging. 2021a; 48(6):1719–23.

Giovanella L, Ruggeri RM, Ovčariček PP, Campenni AG, Treglia, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021b; 9(3):233–40.

Rotondi M, Coperchini F, Ricci G, Denegri M, CroceL, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021; 44(5):1085–90.

Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Ovčariček PP, et al. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev ClinImmunol. 2021; 17(7):737–59. https://doi.org/10.1080/1744666X.2021.1932467.

Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID 19. J Endocrinol Invest. 2021; 44(5):891–904. https://doi.org/10.1007/s40618-021-01506-7.

Van Den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014; 24(10):1456–65. https://doi.org/10.1089/Thy.2014.0201

Moutchia J, Pokharel P, Kerri A, McGaw K, Uchai S, Nji M, et al. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS One. 2020; 15(10):e0239802.

Zou R, Wu C, Zhang S, Wang G, Zhang Q, Yu B, et al. Euthyroid Sick Syndrome in Patients With COVID-19. Front Endocrinol. 2020. https://doi.org/10.3389/fendo.2020.566439

Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021; 42(23):2270–9. https://doi.org/10.1093/eurheartj/ehaa1103.

Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020; 31(6):1157–65. https://doi.org/10.1681/ASN.2020030276.

Lippi G, South AM,Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020; 57(3):262–5. https://doi.org/10.1177/0004563220922255.

Tezcan ME, Gokce GD, Sen N, Kaymak NZ, Ozer RS. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients. New Microbes New Infect. 2020; 37:100753.

Government of India, Ministry of Health and Family Welfare, Director General of Health Services, (EMR division) Version 3-www.mohfw.gov.in[Internet] “Clinical Management Protocol: COVID-19”. [Last accessed on 2020]. Available from: http://www.clinicalestablishments.gov.in/WriteReadData/2801.pdf .

Government of West Bengal, Department of Health and Family Welfare- www.wbhealth.gov.in [Internet]. “Management protocol for COVID-19, second edition”. Available from: https://www.wbhealth.gov.in/uploaded_files/corona/Management_Protocol_for_COVID-19_-_WB_2nd_Edition.pdf .

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7):1131–4. https://doi.org/10.1515/cclm-2020-0198.

Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jiehehe Hu Xi Za Zhi. 2020a; 43(0):E005.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507–13.

Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7):1730–41. https://doi.org/10.1111/all.14238.

Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al.Thyroid Function Before, During, and After COVID-19. J Clin Endocrinol Metab. 2021; 106(2):e803–11. https://doi.org/10.1210/clinem/dgaa830.

Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2020; 44(5):1031–40. https://doi.org/10.1007/s40618-020-01460-w

Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2): e926–35.

Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020; (9):739–41. https://doi.org/10.1016/S2213-8587(20)30266-7.

Chen M, Zhou W, Xu W. Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study Thyroid. 2021; 31(1):8–11. https://doi.org/10.1089/thy.2020.0363.

Sen K, Sinha A, Sen S,Chakraborty S, Alam MS. Thyroid Function Test in COVID-19 Patients: A Cross-Sectional Study in a Tertiary Care Hospital. Indian J Endocrinol Metab. 2020; 24(6):532–6.

- Yazan CD, Ilgin C, Elbasan O, Apaydin T, Dashdamirova S, Yigit T, et al. The Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19. International Journal of Endocrinology. 2021; 2021. https://doi.org/10.1155/2021/2395212.

Llamas M, Garo ML, Giovanella L. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis. Clin Chem Lab Med. 2021; 59(12):1906–13. https://doi.org/10.1515/cclm-2021-0805.

Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest. 2020; 43(10):1527–8.

Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, et al. Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-Centre case series. QJM. 2020; 113(7):474–81.

Xiang T, Liu J, Xu F, Cheng N, Liu Y, Qian K. Analysis of clinical features of 49 patients with new type of coronavirus pneumonia in Jiangxi. Chin J of Respir Crit Care. 2020; 19:154–60.

Gheorghe G, Ilie M, Bungau S, Stoian AMP, Bacalbasa N, Diaconu CC. Is There a Relationship between COVID-19 and Hyponatremia? Medicina. 2021; 57(1):55. https://doi.org/10.3390/medicina57010055